MondegarAI
Forefront Analytics, LLC

Q1 2026 · 13F-HR

Forefront Analytics, LLCholdings as filed

Filed 2026-05-13 · accession 0001696802-26-000003

$110.0M
Reported value
39
Positions
2026-03-31
Period end
View analyzed profile →PRO

The Brief · Forefront Analytics, LLC · Q1 2026

AI · grounded in 13F

Forefront Analytics, LLC closed its position in AOK, reducing its exposure by $2.35M. The fund also exited positions in EMLP and IEI, totaling $698,000 and $566,000 respectively. On the buy side, the fund established a new position in SCHD worth $463,851 and increased its holdings in ESGG by 92.35%.

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
46435G516ESGDISHARES TR$24.3M22.1%254,427CommonSOLE
46434G863ESGEISHARES INC$16.8M15.3%369,453CommonSOLE
922042858VWOVANGUARD INTL EQUITY INDEX F$9.7M8.86%180,162CommonSOLE
46429B663HDVISHARES TR$9.2M8.40%68,087CommonSOLE
67092P300NULVNUSHARES ETF TR$8.9M8.10%195,657CommonSOLE
33939L688ESGGFLEXSHARES TR$8.8M8.04%44,239CommonSOLE
233051200DBEFDBX ETF TR$6.3M5.70%126,892CommonSOLE
46432F396MTUMISHARES TR$5.8M5.29%24,234CommonSOLE
921943858VEAVANGUARD TAX-MANAGED FDS$3.0M2.76%47,307CommonSOLE
464287200IVVISHARES TR$2.9M2.66%4,474CommonSOLE
67066G104NVDANVIDIA CORPORATION$2.5M2.26%14,241CommonSOLE
46434G509HEEMISHARES INC$2.2M1.97%58,540CommonSOLE
46625H100JPMJPMORGAN CHASE & CO$1.5M1.33%4,984CommonSOLE
244199105DEDEERE & CO$640,1590.58%1,136CommonSOLE
91324P102UNHUNITEDHEALTH GROUP INC$536,5590.49%1,983CommonSOLE
28176E108EWEDWARDS LIFESCIENCES CORP$526,4460.48%6,574CommonSOLE
002824100ABTABBOTT LABORATORIES$517,7260.47%5,043CommonSOLE
97717W562EESWISDOMTREE TR$477,8810.43%8,232CommonSOLE
808524797SCHDSCHWAB STRATEGIC TR$463,8510.42%15,119CommonSOLE
G5960L103MDTMEDTRONIC PLC$460,8940.42%5,319CommonSOLE
74347R107SSOPROSHARES TR$423,5640.39%8,164CommonSOLE
45337C102INCYINCYTE CORP$398,4100.36%4,233CommonSOLE
74347R842UWMPROSHARES TR$372,9000.34%7,990CommonSOLE
717081103PFEPFIZER INC$367,5780.33%13,090CommonSOLE
095924106OTFBLUE OWL TECHNOLOGY FIN CORP$367,4130.33%29,654CommonSOLE
75886F107REGNREGENERON PHARMACEUTICALS$355,0290.32%460CommonSOLE
883556102TMOTHERMO FISHER SCIENTIFIC INC$284,5530.26%579CommonSOLE
52490G102LEGNLEGEND BIOTECH CORP$283,2710.26%15,659CommonSOLE
922908744VTVVANGUARD INDEX FDS$258,4730.24%1,317CommonSOLE
235851102DHRDANAHER CORP DEL$244,1680.22%1,288CommonSOLE
718172109PMPHILIP MORRIS INTL INC$239,6640.22%1,450CommonSOLE
25434V815DFSVDIMENSIONAL ETF TRUST$222,1890.20%6,341CommonSOLE
65487U108NKTXNKARTA INC$92,4920.08%43,835CommonSOLE
G9TY5A101ZURAZURA BIO LTD$88,6610.08%14,901CommonSOLE
374163103GERNGERON CORP$82,1360.07%55,125CommonSOLE
03589W102ANNXANNEXON INC$78,8900.07%14,240CommonSOLE
088786108BCYCBICYCLE THERAPEUTICS PLC$66,7880.06%14,394CommonSOLE
23284F105CTMXCYTOMX THERAPEUTICS INC.$58,6370.05%12,476CommonSOLE
589492107MREOMEREO BIOPHARMA GROUP PLC$42,1670.04%127,778CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.